OTC healthcare in China
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 1999-2004
2.11 Life Expectancy
Table 2 Life Expectancy at Birth 1999-2004
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 1999-2004
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 1999-2004
3.2 Market Performance by Region
Table 5 Sales of OTC Healthcare by Region: Value 1999-2004
Table 6 Sales of OTC Healthcare by Region: % Value Growth 1999-2004
3.3 Switches
3.4 Key Trends and Developments
3.5 Competitive Environment
Table 7 OTC Healthcare Company Shares 2001-2004
Table 8 OTC Healthcare Brand Shares 2001-2004
3.6 Leading Company Profiles β Beijing Tongrentang Group Co Ltd
Summary 1 Beijing Tongrentang Group Co Ltd Operational Indicators 2004
Summary 2 Beijing Tongrentang Group: Production Statistics 2003
Table 9 Beijing Tongrentang Group Shares of OTC Healthcare by Subsector 2001-2004
3.7 Leading Company Profiles β Joincare Pharmaceutical Group Industry Co Ltd
Summary 3 Joincare Pharmaceutical Group Industry Co Ltd Operational Indicators 2003
Table 10 Joincare Pharmaceutical Group Industry Co Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.8 Leading Company Profiles β Minsheng Pharm
Summary 4 Minsheng Pharm Operational Indicators 2003-2004
Table 11 Minsheng Pharm Shares of OTC Healthcare by Subsector 2001-2004
3.9 Leading Companies β GlaxoSmithKline (Tianjin) Pharm Co Ltd
3.10 Leading Company Profiles β Shanghai Johnson & Johnson Pharmaceutical Ltd
3.11 Leading Company Profiles β Shanghai Roche Pharm Co Ltd
3.12 Leading Company Profiles β Shanghai Squibb Pharmaceuticals Ltd
3.13 Leading Company Profiles β Sanjiu Enterprise Group
3.14 Leading Company Profiles β Xian Janssen Pharmaceutical Ltd
3.15 Emerging and Niche Companies
3.16 Retail Distribution
Table 12 Sales of OTC Healthcare by Distribution Format: % Analysis 1999/2004
Table 13 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2004
3.17 Retailer Activity and Private Label Trends
3.18 Forecast Market Performance
Table 14 Forecast Sales of OTC Healthcare by Sector: Value 2004-2009
Table 15 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2004-2009
3.19 Forecast Market Performance by Region
Table 16 Sales of OTC Healthcare by Region: Value 2004-2009
Table 17 Sales of OTC Healthcare by Region: % Value Growth 2004-2009
4. WOUND TREATMENTS SALES
4.1 Sector Performance
Table 18 Sales of Wound Treatments by Subsector: Value 1999-2004
Table 19 Sales of Wound Treatments by Subsector: % Value Growth 1999-2004
Table 20 Wound Treatments Company Shares 2001-2004
Table 21 Wound Treatments Brand Shares 2001-2004
Table 22 Forecast Sales of Wound Treatments by Subsector: Value 2004-2009
Table 23 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
4.2 Sector Performance by Region
Table 24 Sales of Wound Treatments by Region: Value 1999-2004
Table 25 Sales of Wound Treatments by Region: % Value Growth 1999-2004
Table 26 Forecast Sales of Wound Treatments by Region: Value 2004-2009
Table 27 Forecast Sales of Wound Treatments by Region: % Value Growth 2004-2009
5. OTHER OTC
6. DEFINITIONS
